ArticleComputational and structural biotechnology journal2026
The State of Peptide Detectability in Computational Proteomics and Guidelines for AI Applications.
Article in Computational and structural biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Combined NGS and proteomics improves viral diagnostics in wildlife: coronaviruses confirmed in hedgehogs.Frontiers in cellular and infection microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial intelligence (AI) techniques have transformed proteomics and computational biology over the past decade, particularly in mass spectrometry tasks such as fragment spectra prediction, retention time prediction, and peptide detectability prediction. However, as the volume of proteomics data grows, the need for robust, reproducible, and comparable AI applications has become increasingly urgent. Here, we present a comprehensive scoping review of AI techniques for peptide detectability, an essential and rapidly evolving problem in computational proteomics. By analyzing more than 25 peer-reviewed methods published between 2006 and 2025, we identify a persistent discrepancy between increasing algorithmic sophistication and consistent adherence to established machine learning standards. Current studies frequently exhibit heterogeneity in dataset construction, limited transparency in model design and evaluation, and restricted reproducibility. To address these challenges, we propose actionable guidelines focused on transparent technical reporting, rigorous dataset separation, comprehensive performance evaluation, and reproducibility. Encouragingly, recent tools demonstrate that such standards can be met in practice. Furthermore, we outline a future research agenda that emphasizes the integration of structural biology frameworks, the transition toward data-independent acquisition datasets, and the development of explainable AI to ensure models are both biologically interpretable and transferable across evolving instrument platforms. While centered on peptide detectability, these principles offer valuable insights and can inform future work across a wide range of computational proteomics applications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.